NFKB1 and neoplasm: It selectively targets the NF-κB signaling pathway and induces oxidative stress to eliminate malignant cells, potentially enhancing anti-tumor activity against progenitor lymphoid cells (Belloucif and Lobry, 2022; Mohammadi et al., 2017).